Latest News
Conference Coverage
Three antiseizure medications join list for newborn risks
A Scandinavian study of 4.5 million births adds carbamazepine, oxcarbazepine, and topiramate to list of antiseizure drugs linked to low birth...
Latest News
Immune dysregulation may drive long-term postpartum depression
"This work highlights the need for standardized and continual depression and anxiety screening in ob.gyn. and primary care settings."
Latest News
Breaking bad news during IVF: How to soften the blow
Two years ago, Ashley Hingston had a miscarriage. The 35-year-old Floridian and her husband had been going through in vitro fertilization when...
Conference Coverage
High response rates with T-DXd in early HER2-low breast cancer
Nearly 70% of patients with hormone receptor-positive breast cancers with low levels of HER2 had pathological response to the antibody-drug...
Latest News
More states to consider extending postpartum Medicaid coverage beyond 2 months
High U.S. maternal mortality rates are driving the proposals, as is the expectation that more women will need postpartum care as state abortion...
Commentary
No, you can’t see a different doctor: We need zero tolerance of patient bias
While speech may not constitute violence in the strictest sense of the word, there is growing evidence that it can be physically harmful.
Feature
States cracking down harder on docs who sexually abuse patients
The Federation of State Medical Boards conducted a 2-year review of how medical boards handled cases of sexual misconduct.
Latest News
Postpartum hemorrhage rates and risk factors rising
Despite increased hemorrhage rates, blood transfusions and peripartum hysterectomies declined in recent years.
Conference Coverage
Oral SERD camizestrant prolongs PFS vs. fulvestrant in breast cancer
The investigational selective estrogen receptor degrader showed efficacy in advanced ER+/HER2– breast cancers, including patients with ESR1...
Conference Coverage
Potential cause of worse outcomes among Black breast cancer patients found
Tumor microenvironment of metastasis doorways predicted worse outcomes in Black women with residual ER+/HER2– cancer after neoadjuvant...
Latest News
They trusted their prenatal test. They didn’t know the industry is an unregulated ‘Wild West.’
As regulators stay on the sidelines, a growing industry expands its reach but leaves some pregnant patients feeling misled and heartbroken.